Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-12-28

Clinical Trial Update: The Effect of Amantadine on Post-COVD-19 Fatigue [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating the effect of amantadine on fatigue in Post-COVID-19 Syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • amantadine (amantadine)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Post-COVID-19 Syndrome | Phase 2 | Status: UNKNOWN